[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pancreatic-cystic-lesion\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pancreatic-cystic-lesion":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,50],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":30,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":5},"100628610","management-of-pancreatic-cystic-lesions-using-artificial-intelligence-based-on-eus-and-multimodal-data-100628610",false,"NCT07463872","Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data","A Multimodal Artificial Intelligence Model for Subtyping Diagnosis and Clinical Management of Pancreatic Cystic Lesions Based on Endoscopic Ultrasound and Clinical Information","Inclusion criteria:\n\n* Patients whose EUS results indicates pancreatic cystic or cystoid lesions;\n* Mucinous lesions: including mucinous cystic neoplasm (MCN), intraductal papillary mucinous neoplasm (IPMN);\n* Non-mucinous lesions: including pancreatic pseudocyst, serous cystic neoplasm (SCN), cystic neuroendocrine tumor (cNET).\n\nExclusion criteria:\n\n* Patients whose age is less than 18 years old;\n* Patients who have undergone pancreatic surgery before the EUS examination;\n* Patients who have received chemotherapy and radiotherapy for pancreatic tumors before the EUS examination;\n* Pathological results indicate that pancreatic lesions are metastatic lesions from other sites;\n* Patients whose EUS images or reports are missing;\n* EUS image quality does not meet the requirements for review, such as blurry imaging or containing artifacts, biopsy needles, measuring scales, or other additional annotations that are not part of the original EUS image;\n* Patients whose final diagnosis is unclear.","ALL","18 Years",{"count":19,"type":20},500,"ESTIMATED","OBSERVATIONAL","The primary objective is to construct a multimodal AI model (Cyst-AI) based on EUS images and clinical data such as imaging features(CT or MRI) and laboratory tests to assist endoscopists in the diagnosis of pancreatic cystic lesions(PCLs), mainly differentiating mucinous from non-mucinous lesions.\n\nThe secondary objective is to evaluate the model's effectiveness in risk stratification and clinical management for patients with PCLs.",[24,25,26,27,28,29],"Pancreatic Cystic Lesion","Mucinous Cystadenoma of Pancreas","Intraductal Papillary Mucinous Neoplasm of Pancreas","Pseudocyst Pancreas","Serous Cystadenoma","Neuroendocrine Tumors, NET",[31,32,33,34,35,36,37],"pancreatic cystic lesions","artificial intelligence","endoscopic ultrasound","multimodal","differentiation","risk stratification","clinical management","RECRUITING","2026-03-05",{"date":41,"type":42},"2026-03-11","ACTUAL",{"date":44,"type":42},"2025-01-01",{"date":46,"type":20},"2026-06",{"name":48,"class":49},"Huazhong University of Science and Technology","OTHER",{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":58,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":60,"conditions":61,"keywords":62,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":76},"100557236","antibiotic-prophylaxis-for-eus-fna-of-pancreatic-cystic-lesions-100557236","NCT06535490","Antibiotic Prophylaxis for EUS-FNA of Pancreatic Cystic Lesions","Prevention of Infection After EUS-FNA of Pancreatic Cystic Lesions: A French Multicenter Prospective Comparative Observational Study","PrePaCyst","Inclusion Criteria:\n\n* Patient referred for diagnostic aspiration of a pancreatic cystic lesion\n* Patient aged 18 years or older\n* Patient with ASA 1, ASA 2, ASA 3 status\n* No participation in another concurrent clinical study\n\nExclusion Criteria:\n\n* Patient under 18 years old\n* Patient with ASA 4 or ASA 5 status\n* Pregnant woman\n* Patient with coagulation disorders preventing the performance of an EUS-FNA: PT \\\u003C 50%, platelets \\\u003C 50,000\u002Fmm³, current effective anticoagulation, ongoing clopidogrel, prasugrel, or ticagrelor treatment\n* Patient unable to personally express non-opposition or legally protected adult",{"count":59,"type":20},1702,"Large prospective comparative observational study in numerous reference centers in France, comparing infectious complications in patients admitted for pancreatic cystic lesions (PCL) aspiration performed with or without antibiotic prophylaxis (ATBp) according to the usual practices.\n\nThis is a prospective, comparative, observational, multicenter study, with the primary objective of comparing the infection rates in pancreatic cystic lesions (PCL) aspirated under EUS, with and without the administration of ATBp.\n\nA sample size of 1702 patients will be needed over a 3-year study period.",[24],[63,64,65],"EUS-FNA","Pancreatic cystic lesion","Antibiotic prophylaxis","NOT_YET_RECRUITING","2024-08-01",{"date":69,"type":42},"2024-08-02",{"date":71,"type":20},"2024-09-15",{"date":73,"type":20},"2027-10-15",{"name":75,"class":49},"Société Française d'Endoscopie Digestive",1]